U.S. Markets close in 1 hr 19 mins
  • S&P 500

    4,315.89
    -117.10 (-2.64%)
     
  • Dow 30

    33,697.13
    -887.75 (-2.57%)
     
  • Nasdaq

    14,563.53
    -480.44 (-3.19%)
     
  • Russell 2000

    2,163.88
    -72.99 (-3.26%)
     
  • Crude Oil

    70.38
    -1.59 (-2.21%)
     
  • Gold

    1,762.40
    +11.00 (+0.63%)
     
  • Silver

    22.16
    -0.14 (-0.63%)
     
  • EUR/USD

    1.1730
    -0.0001 (-0.0117%)
     
  • 10-Yr Bond

    1.3060
    -0.0640 (-4.67%)
     
  • Vix

    27.75
    +6.94 (+33.35%)
     
  • GBP/USD

    1.3650
    -0.0088 (-0.6374%)
     
  • USD/JPY

    109.3300
    -0.5650 (-0.5141%)
     
  • BTC-USD

    44,590.88
    -3,435.44 (-7.15%)
     
  • CMC Crypto 200

    1,081.27
    -53.12 (-4.68%)
     
  • FTSE 100

    6,903.91
    -59.73 (-0.86%)
     
  • Nikkei 225

    30,500.05
    +176.75 (+0.58%)
     

3 Things About Vertex Pharmaceuticals That Smart Investors Know

·4 min read
3 Things About Vertex Pharmaceuticals That Smart Investors Know
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Cystic fibrosis is a deadly lung disease that causes patients to fight for every breath. Vertex Pharmaceuticals (NASDAQ: VRTX) delivered on that hope with therapies showing remarkable improvements in lung capacity -- changing the lives of and bringing relief to people with the condition. In 2019, Vertex introduced Trikafta, a highly effective triple combination of therapies.